• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: August 14-18

News
Article

ICYMI, this week we had stories about counting down to Fall Clinical in Vegas, clascoterone cream 1% for acne vulgaris management, VP-315 for basal cell carcinoma lesions, and more.

Countdown to Fall Clinical Vegas: Reviewing the Top 5 Headlines From Fall Clinical for PAs and NPs

Dermatology Times is counting down to the annual Fall Clinical conference in Las Vegas, Nevada, with our top 5 headlines and highlights from this year's PA and NP summer conference.

Frontline Forum Part 1: A Greater Understanding of the Acne Vulgaris Armamentarium

In part 1 of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD, discuss the pathogenesis of acne vulgaris, the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.

A Time for Reflection on Dermatology Residency

Dermatology Times Editor in Chief Zoe Diana Draelos, MD, reflects on the importance of dermatology residency programs in cultivating early passion for the specialty.

POLL: What Percentage of People Worldwide Will Experience Alopecia in Their Lifetime?

This Hair Loss Awareness Month, test your knowledge of hair loss conditions. Click here to answer this week's poll.

Uptitration of Baricitinib Effective in Improving Hair Growth in Patients With Alopecia Areata

Patients with episodes longer than 4 years had a delayed response rate.

Combining UV Filters and Active Ingredients Provides Better Photoprotection

Mannitol and ectoine, when used with UV filters in sunscreen, can provide a higher level of skin protection.

Practical Back-to-School Tips: Educating Patients and Their Caregivers on Skin Health

As your youngest patients begin the return to the classroom, pediatric dermatologist Latanya Benjamin, MD, FAAD, FAAP, offers perspectives in education and skin care tips.

Sex Differences Contribute to Immunological Functioning Influences HS

Female sex bias in hidradenitis suppurativa can be attributed to several contributing immunological factors.

Journal Digest: August 15

This week’s collection of the latest dermatologic studies covers distinguishing between granular cell tumors and melanoma, methotrexate and biologics for anxiety and depression among PsO patients, botulinum toxin for scalp conditions, and a review of the SPRING study for guselkumab.

Artificial Intelligence Virtual Clinic Launches in Massachusetts

Piction Health Dermatology seeks to break down barriers in dermatologic care access.

Study Uncovers Gaps in Skin Cancer Prevention Among Volunteer Firefighters

The study is the first large study to assess skin cancer screening efforts aimed at volunteer firefighters in the US.

Combination Hyaluronic Acid/Calcium Hydroxyapatite Filler Increases Skin Volume

Results showed that the hybrid filler significantly increased collagen fibers with minimal adverse events.

Minoxidil Combined With Laser Treatment Improves Hair Condition in Androgenetic Alopecia

The results showed that minoxidil with laser resulted in a slightly better dermoscopy score than minoxidil alone.

Frontline Forum Part 2: A Greater Understanding of the Acne Vulgaris Armamentarium

In part 2 of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; Leon Kircik, MD, discuss the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.

Psoriasis Updates: Year Thus Far

This Psoriasis Awareness Month, Dermatology Times is looking back at the treatment and research landscape of 2023.

Pointers With Portela: Microneedling FAQs

In this week’s Pointers With Portela, the 208SkinDoc answers frequently asked questions about microneedling and its benefits.

Lichen Sclerosus Present in 82% of Penile Melanomas

While the linkage between squamous cell cancers and genital lichen sclerosus has been well-established, fewer studies have examined the associations between penile melanomas in males.

Cantella Triterpenes Cream May be a Potential Hypertrophic Scar Treatment

Researchers found that STAT3 could be activated, and inhibition could be achieved in patients with hypertrophic scarring.

VP-315 Effective in Clearing Basal Cell Carcinoma Lesions

Most of the patients receiving the non-surgical treatment experienced a complete clearing of tumors.

Patients With Blood Type A had a Higher Incidence of Severe Acne

ABO blood type appeared to be a factor in severity of acne vulgaris.

Addressing Unmet Needs in Psoriasis Treatment

Five nurse practitioners and physician assistants review patient case presentations and discuss unmet needs in the psoriasis landscape.

Dupilumab Injections Show Promise in Chronic Prurigo and Inflammation

A Zurich case series is demonstrating the efficacy of dupilumab injections in patients with inflammation and chronic prurigo.

Disclosing Physician Health: What Is Required?

In this month's Legal Eagle, learn what clinicians are required to disclose about their personal health ahead of performing procedures.

31-Gene Expression Profile Test Accurately Classified Risk of Death From Melanoma

Patients with the DecisionDx-Melanoma 31-gene expression profile test had a 29% lower melanoma-specific survival mortality.

Treating and Preventing Postinflammatory Hypo- and Hyperpigmentation

UV exposure or trauma to the skin, such as blistering and ulceration, can lead to changes in skin pigmentation and appearance.

Progression-Free Survival of BRAF-Mutant Melanoma Improved by Combination Therapy

A combined treatment regimen of encorafenib and binimetinib led to improved progression-free survival, overall response rate, and tolerability in patients with advanced BRAF-mutant melanoma.

5 Money Mistakes Dermatologists Make and How to Avoid Them

David Mandell, JD, MBA, is here to help ensure new and novice clinicians understand the impact of taxes, lifestyle creep, investment plans, and more.

Patients With Pemphigus Vulgaris Given Rituximab did not Experience More Severe COVID-19

Total dose and number of cycles of rituximab were not associated with duration or severity of COVID-19 disease.

DERMACLEAR Study, NLP System Increase Real-World Evidence of Clinical Practice

The DERMACLEAR study has retrospectively obtained data from more than 54,000 patients, and the NLP system had greater than 95% precision.

Evan Rieder, MD: Equipping Patients With Tools for Skin Acceptance

Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.

Patients Grade Disease Severity Higher Than Physicians

Patient and physician demographics were not significantly associated with discordance.

Leah Howard, JD: Advocacy in Chronic Skin Conditions

Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and National Psoriasis Foundations President and CEO Leah Howard, JD, discusses the importance of advocacy and mental health in chronic skin conditions.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.